-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Initiates Coverage On Kestra Medical Techs with Overweight Rating, Announces Price Target of $30

Benzinga·08/10/2026 10:10:20
Listen to the news
JP Morgan analyst Robbie Marcus initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Overweight rating and announces Price Target of $30.